American Epilepsy Society Annual Course 2005 The Evidence for How We Diagnose and Treat Epilepsy Patients
Article first published online: 14 DEC 2006
Volume 47, Issue 12, page 2211, December 2006
How to Cite
(2006), American Epilepsy Society Annual Course 2005 The Evidence for How We Diagnose and Treat Epilepsy Patients. Epilepsia, 47: 2211. doi: 10.1111/j.1528-1167.2006.00947.x
- Issue published online: 14 DEC 2006
- Article first published online: 14 DEC 2006
Vol. 47, Issue Supplement s1, 41–45, Article first published online: 11 OCT 2006
The guest editors for this Supplement, and their affiliations, were omitted from the cover and table of contents. The publisher apologizes for this error. The guest editors and their affiliations are as follows:
Guest Editors — Orrin Devinsky, MD and Peter Camfield, MD
Dr. Devinsky's affiliation should have been listed as Neurology, Neurosurgery & Psychiatry, NYU School of Medicine. Dr. Camfield's affiliation should have been listed as Pediatrics, Dalhousie University and the IWK Health Centre.
The summary on page 41, for the article “In Nonconvulsive Status Epilepticus (NCSE), Treat to Burst-Suppression: Pro and Con” by Kenneth G. Jordan and Lawrence J. Hirsch, was printed incorrectly. The correct summary follows:
Summary: Dr. Jordan (PRO) argues that when refractory NCSE is combined with acute brain injury, it produces synergistically compounded brain damage that is time dependent. Treating to EEG burst-suppression is the most rapid and effective method for stopping NCSE. The risks of burst-suppression are common to many intensive care interventions and can be minimized with expert management. Dr. Hirsch (CON) argues that treating with coma-inducing medication is highly risky and has a high mortality rate, often due to iatrogenic complications. It remains unclear if nonconvulsive seizures cause permanent neuronal injury. Nonconvulsive seizures should be diagnosed and treated as quickly as possible, but with non-coma-inducing treatments in most cases.